Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten Fuereder

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
Oncology|January 20, 2022
Oral Abundance of Actinomyces spp. in Breast Cancer PatientsCeren Bilgilier, Thorsten Fuereder, Marie-Theres Kastner, et al.
Cancers|September 9, 2020
Gemcitabine and Platinum-Based Agents for the Prediction of Cancer-Associated Venous Thromboembolism: Results from the Vienna Cancer and Thrombosis StudyFlorian Moik, Nick van Es, Florian Posch, et al.
Biomolecules|November 27, 2021
Overweight as a Favorable Clinical Biomarker for Checkpoint Inhibitor Therapy Response in Recurrent Gynecologic Cancer PatientsThomas Bartl, Arina Onoprienko, Gerda Hofstetter, et al.
Cancer Letters|May 18, 2010
mTOR inhibition by everolimus counteracts VEGF induction by sunitinib and improves anti-tumor activity against gastric cancer in vivoThorsten Fuereder, Agnes Jaeger-Lansky, Doris Hoeflmayer, et al.
Molecular Oncology|December 10, 2024
SKA1 promotes oncogenic properties in oral dysplasia and oral squamous cell carcinoma, and augments resistance to radiotherapyAlexander Michael Grandits, Barbara Andrea Reinoehl, Renate Wagner, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 16, 2024
Prediction of 90-day mortality risk after unplanned emergency department visits of advanced stage cancer patientsGeorg Jeryczynski, Christoph Krall, Sabina Pasalic, et al.
Frontiers in Oncology|August 26, 2022
Chemotherapy-associated oral microbiome changes in breast cancer patientsIngeborg Klymiuk, Ceren Bilgilier, Alexander Mahnert, et al.
Scientific Reports|August 18, 2016
The association of medication-related osteonecrosis of the jaw with Actinomyces spp. infectionGuenter Russmueller, Rudolf Seemann, Kathrin Weiss, et al.
Anti-Cancer Drugs|March 2, 2011
Sphingosine kinase 1 is a relevant molecular target in gastric cancerThorsten Fuereder, Doris Hoeflmayer, Agnes Jaeger-Lansky, et al.
International Journal of Molecular Sciences|February 15, 2022
<i>EVI1</i> Promotes the Proliferation and Invasive Properties of Human Head and Neck Squamous Cell Carcinoma CellsAlexander Michael Grandits, Sophie Bromberger, Gerwin Heller, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Oncology|January 20, 2022
Oral Abundance of Actinomyces spp. in Breast Cancer PatientsCeren Bilgilier, Thorsten Fuereder, Marie-Theres Kastner, et al.
Cancers|September 9, 2020
Gemcitabine and Platinum-Based Agents for the Prediction of Cancer-Associated Venous Thromboembolism: Results from the Vienna Cancer and Thrombosis StudyFlorian Moik, Nick van Es, Florian Posch, et al.
Biomolecules|November 27, 2021
Overweight as a Favorable Clinical Biomarker for Checkpoint Inhibitor Therapy Response in Recurrent Gynecologic Cancer PatientsThomas Bartl, Arina Onoprienko, Gerda Hofstetter, et al.
Cancer Letters|May 18, 2010
mTOR inhibition by everolimus counteracts VEGF induction by sunitinib and improves anti-tumor activity against gastric cancer in vivoThorsten Fuereder, Agnes Jaeger-Lansky, Doris Hoeflmayer, et al.
Molecular Oncology|December 10, 2024
SKA1 promotes oncogenic properties in oral dysplasia and oral squamous cell carcinoma, and augments resistance to radiotherapyAlexander Michael Grandits, Barbara Andrea Reinoehl, Renate Wagner, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 16, 2024
Prediction of 90-day mortality risk after unplanned emergency department visits of advanced stage cancer patientsGeorg Jeryczynski, Christoph Krall, Sabina Pasalic, et al.
Frontiers in Oncology|August 26, 2022
Chemotherapy-associated oral microbiome changes in breast cancer patientsIngeborg Klymiuk, Ceren Bilgilier, Alexander Mahnert, et al.
Scientific Reports|August 18, 2016
The association of medication-related osteonecrosis of the jaw with Actinomyces spp. infectionGuenter Russmueller, Rudolf Seemann, Kathrin Weiss, et al.
Anti-Cancer Drugs|March 2, 2011
Sphingosine kinase 1 is a relevant molecular target in gastric cancerThorsten Fuereder, Doris Hoeflmayer, Agnes Jaeger-Lansky, et al.
International Journal of Molecular Sciences|February 15, 2022
<i>EVI1</i> Promotes the Proliferation and Invasive Properties of Human Head and Neck Squamous Cell Carcinoma CellsAlexander Michael Grandits, Sophie Bromberger, Gerwin Heller, et al.
Pageof 8